Complete Genomics Files for IPO; Sequenced About 200 Human Genomes So Far this Year

Complete Genomics plans to raise up to $86.25 million in its IPO, according to filings with the SEC. Since its inception through March 31, the company has brought in revenues of $959,000 and accumulated a net loss of $95.5 million.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.